China Shineway Pharmaceutical Group Limited (HK:2877) has released an update.
China Shineway Pharmaceutical Group Limited announced successful passage of all resolutions during their Annual General Meeting on May 31, 2024. Shareholders voted overwhelmingly in favor of key decisions including the re-election of directors, general mandates for share dealings, and the re-appointment of their auditor. This reflects a strong endorsement from the shareholders of the company’s direction and governance.
For further insights into HK:2877 stock, check out TipRanks’ Stock Analysis page.
